Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_3
6
75%
Ph not_applicable
1
13%
Ph phase_4
1
13%

Phase Distribution

0

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
6(75.0%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Terminated(1)

Detailed Status

Completed7
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 36 (75.0%)
Phase 41 (12.5%)
N/A1 (12.5%)

Trials by Status

terminated113%
completed788%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8